Abingdon Health (LON:ABDX) Stock Price Up 12.8% – Time to Buy?

Abingdon Health Plc (LON:ABDXGet Free Report)’s share price rose 12.8% during trading on Wednesday . The company traded as high as GBX 7.05 and last traded at GBX 7.05. Approximately 496,768 shares traded hands during mid-day trading, an increase of 249% from the average daily volume of 142,462 shares. The stock had previously closed at GBX 6.25.

Abingdon Health Stock Up 12.8%

The company has a market cap of £13.65 million, a P/E ratio of -9.66 and a beta of 0.13. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The company has a fifty day moving average of GBX 5.96 and a 200 day moving average of GBX 6.23.

Abingdon Health Company Profile

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.

Featured Articles

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.